Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Thermo Scientific is Featuring New Twin-Screw Extruder at AAPS 2012

Published: Tuesday, October 16, 2012
Last Updated: Tuesday, October 16, 2012
Bookmark and Share
Fully scalable Thermo Scientific Pharma 11 extruder used for pharmaceutical research.

Thermo Fisher Scientific Inc. will feature its new Thermo Scientific Pharma 11 parallel co-rotating twin-screw extruder at the 2012 AAPS conference.

The 11 mm extruder is designed specifically for pharmaceutical applications to minimize material costs, be easier to use and optimize laboratory space.

To achieve this, the benchtop Pharma 11 uses a minimal amount of sample material (20 g) and features a user-friendly touchscreen with integrated feeder control.

To deliver performance as requested by today’s pharma developers, Thermo Fisher, for the first time, offers a complete strandline, containing air-cooled conveyor belt and adjustable pelletizer, all with the convenient footprint of a standard fumehood.

Today’s researchers and scientists face multiple challenges, from resource constraints to limited lab space and budgets. Pharma 11 meets these challenges head-on by delivering a small, simple-to-use and scalable extruder.

“Since its introduction six months ago, our customers have extensively tested Pharma 11 in real-life applications. And, time after time, researchers and scientists have confirmed the tagline ‘Small, Simple, Scalable’ in every aspect,” said Charndeep Khattar, Director product line Process/Pharma Instruments at Thermo Fisher.

Khattar continued, “With its compact footprint and minimal sample material use, Pharma 11 simplifies the testing process and enables scientists to focus on delivering world-class pharmaceutical research. It is no wonder that the number of Pharma 11 extruders deployed worldwide today has exceeded all expectations.”

The new Pharma 11 extruder features a throughput of 20 g/h to 2.5 kg/h and is easily convertible from hot melt extrusion (HME) to twin screw granulation (TSG) applications.

The Pharma 11 extruder is ideal for a wide range of drug development applications including drug delivery systems, implants, tablets and granules.

The GMP-compliant device is also suitable for clinical trials, and the compact design makes it ideal for glove box applications.

Thermo Fisher, one of the pioneers in rheology, successfully supports a wide range of industries with its comprehensive Thermo Scientific material characterization solutions.

Material characterization solutions analyze and measure viscosity, elasticity, process ability and temperature-related mechanical changes of plastics, food, cosmetics, pharmaceuticals and coatings, chemical or petrochemical products, plus a wide variety of liquids or solids.

For more information, please visit www.thermoscientific.com/mc.

Thermo Fisher will showcase the Pharma 11 extruder in Thermo Scientific booth 4519 during the 2012 AAPS conference in Chicago, Oct. 14-18.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Scientific Screening Library Advances Drug Discovery Research at Temple University’s Moulder Center
20,000-molecule Maybridge collection will help identify compound candidates to treat a wide range of diseases.
Thursday, October 20, 2011
Scientific News
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Company has announced financing of $30 million to support development of novel therapies to treat gram-negative bacterial infections.
Keeping Tumor Growth at Bay
Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.
Future of Medicine Could be Found in a Tiny Crystal Ball
A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.
Improving Delivery of Poorly Soluble Drugs Using Nanoparticles
A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Faster Drug Discovery?
Startup develops more cost-effective test for assessing how cells respond to chemicals.
New Mechanism of Antitumor Action Identified
A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.
Nanoparticles Deliver Tumor Suppressors to Damaged Livers
UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
Experimental Combination Surprises with Anti-HIV Effectiveness
A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.
A New Type of Anticancer Agent
Success in the development of a ?-tubulin specific inhibitor.
Nanoparticles Proven Effective Against Antibiotic-Resistant “Superbugs”
In the ever-escalating evolutionary battle with drug-resistant bacteria, humans may soon have a leg up thanks to adaptive, light-activated nanotherapy developed by researchers at the University of Colorado Boulder.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!